Close Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14K Hold
220
﹤0.01% 217
2025
Q4
$15K Hold
220
﹤0.01% 219
2025
Q3
$15K Sell
220
-44
-17% -$3.48K ﹤0.01% 222
2025
Q2
$23K Hold
264
﹤0.01% 199
2025
Q1
$18K Hold
264
﹤0.01% 194
2024
Q4
$21K Hold
264
﹤0.01% 193
2024
Q3
$18K Hold
264
﹤0.01% 204
2024
Q2
$30K Hold
264
﹤0.01% 183
2024
Q1
$37K Hold
264
﹤0.01% 167
2023
Q4
$33K Hold
264
﹤0.01% 165
2023
Q3
$25K Hold
264
﹤0.01% 165
2023
Q2
$34K Hold
264
﹤0.01% 172
2023
Q1
$31K Hold
264
﹤0.01% 161
2022
Q4
$30K Buy
264
+176
+200% +$19.3K ﹤0.01% 142
2022
Q3
$7K Buy
88
+66
+300% +$5.59K ﹤0.01% 164
2022
Q2
$2K Sell
22
-66
-75% -$6.02K ﹤0.01% 180
2022
Q1
$12K Hold
88
﹤0.01% 180
2021
Q4
$12K Hold
88
﹤0.01% 180
2021
Q3
$12K Hold
88
﹤0.01% 181
2021
Q2
$9K Hold
88
﹤0.01% 179
2021
Q1
$8K Buy
+88
New +$8.26K ﹤0.01% 191

Other funds holding DXCM

Close Asset Management's DXCM Position: Q1 2026 in Review

Close Asset Management held its DexCom (DXCM) position steady in Q1 2026 at 220 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #217.

Close Asset Management first reported a position in DXCM in Q1 2021 and has held it in 21 quarters since. The position peaked at $37K in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Close Asset Management held 220 shares of DexCom worth $14K as of Q1 2026.
  • Close Asset Management left its DexCom share count unchanged in Q1 2026.
  • DexCom made up ﹤0.01% of Close Asset Management's portfolio in Q1 2026, its #217 holding.
  • Close Asset Management first reported a position in DexCom in Q1 2021 and has held it in 21 quarters since.
  • Close Asset Management's DexCom position peaked at $37K in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.